SHARE CAPITAL | 14. SHARE CAPITAL On March 24, 2021, the Company performed a 3 for 1 share consolidation of the Company’s common shares, stock options, warrants and DSUs. The quantities and per unit prices presented in this note are shown on post consolidation basis. The Company does not intend to issue dividends in the near term. If and when dividends are paid, they may be paid in Canadian or U.S. dollars. 14.1 Authorized 14.2 Issued and Outstanding Common Shares: The details for the common share issuances during the year ended December 31, 2022 are as follows: a. During the year ended December 31, 2022, 4,444,445 12,000 1,283 During the year ended December 31, 2022, the Company also issued 5,118,554 205 6,244 b. During the year ended December 31, 2022, 166,000 c. During the year ended December 31, 2022, 66,661 75 The details for the common share issuances during the year ended December 31, 2021 were as follows: d. During the year ended December 31, 2021, 4,114,242 17,563 3,567 e. During the year ended December 31, 2021, 1,924,721 6,128 f. During the year ended December 31, 2021, 256,662 416 The details for the common share issuances during the year ended December 31, 2020 were as follows: g. During the year ended December 31, 2020, 2,886,373 6,608 h. During the year ended December 31, 2020, 612,578 445 i. During the year ended December 31, 2020, 175,000 300 j. During the year ended December 31, 2020, 133,333 14.3 Share Purchase Warrants A summary of the Company’s share purchase warrants are as follows: Schedule of share purchase warrants Number of Warrants Weighted Average Exercise Price C$ Outstanding, December 31, 2019 — — Issued 1,934,100 3.89 Outstanding, December 31, 2020 1,934,100 3.89 Issued 2,407,304 6.64 Forfeited (9,379 ) 4.50 Exercised (1,924,721 ) 3.89 Outstanding, December 31, 2021 2,407,304 6.64 Issued 5,577,778 3.84 Forfeited (412,000 ) 4.50 Outstanding, December 31, 2022 7,573,082 4.53 During the year ended December 31, 2022, the Company issued 4,444,445 133,333 During the year ended December 31, 2022, the Company issued 1,000,000 During the year ended December 31, 2021, the Company issued 1,995,304 During the year ended December 31, 2021, the Company issued 412,000 During the year ended December 31, 2020, the Company issued 1,584,100 During the year ended December 31, 2020, the Company issued 350,000 14.4 Directors, Consultants, and Employee stock options The Company has adopted a share option plan for which options to acquire up to 10% of the issued share capital, at the award date, may be granted to eligible optionees from time to time. Generally, share options granted have a maximum term of five years, and a vesting period and exercise price determined by the directors. A summary of the Company’s directors, consultants, and employee stock options are as follows: Summary of share option activity Number of Options Weighted Average Exercise Price C$ Outstanding, December 31, 2019 1,213,320 2.25 Issued 433,333 3.15 Forfeited (298,333 ) 2.01 Exercised (175,000 ) 2.22 Outstanding, December 31, 2020 1,173,320 2.70 Issued 684,999 6.71 Exercised (256,662 ) 2.06 Outstanding, December 31, 2021 1,601,657 4.52 Issued 387,500 1.60 Forfeited (341,670 ) 5.21 Exercised (66,661 ) 1.40 Outstanding, December 31, 2022 1,580,826 3.79 During the year ended December 31, 2022, the Company granted 387,500 During the year ended December 31, 2021, the Company granted 524,999 During the year ended December 31, 2021, the Company granted 160,000 During the year ended December 31, 2020, the Company granted 200,000 During the year ended December 31, 2020, the Company granted 233,333 During the year ended December 31, 2022, the Company recognized $ 116 814 531 Schedule of weighted average assumptions December 31, 2022 December 31, 2021 December 31, 2020 Fair value at grant date (C$) $ 0.75 $ 4.20 $ 0.42 Fair value at grant date (US$) $ 0.56 $ 3.27 $ 0.32 Risk-free interest rate 3.47 % 0.42 % 0.30 % Expected life of options 5 4 4 Expected dividend rate 0 % 0 % 0 % Annualized volatility 97 % 90 % 82 % Forfeiture rate 14 % 3 % 3 % The following tables summarize information about the Company’s stock options outstanding at December 31, 2022: Schedule of stock options outstanding Options Outstanding Options Exercisable Exercise Price Remaining Contractual Life (Years) Expiry Date C$ April 4, 2018 83,333 83,333 5.25 0.26 April 4, 2023 April 26, 2018 83,333 83,333 4.35 0.32 April 26, 2023 May 29, 2018 83,333 83,333 4.35 0.41 May 29, 2023 January 17, 2019 166,666 166,666 2.40 1.05 January 17, 2024 November 15, 2019 233,333 233,333 1.50 1.88 November 15, 2024 November 28, 2019 16,666 16,666 1.56 1.91 November 28, 2024 May 4, 2020 24,999 24,999 1.20 2.34 May 4, 2025 November 23, 2020 66,664 66,664 6.15 2.90 November 23, 2025 January 12, 2021 333,333 333,333 6.51 3.03 January 11, 2026 February 1, 2021 41,666 34,722 9.36 3.09 January 31, 2026 April 27, 2021 60,000 30,000 7.24 3.32 April 26, 2026 March 31, 2022 40,000 6,666 2.98 4.25 March 30, 2027 September 22, 2022 250,000 — 1.50 2.73 September 21, 2025 November 25, 2022 97,500 — 1.30 4.90 November 24, 2027 Total 1,580,826 1,163,048 14.5 Restricted Share Units Pursuant to the Company’s Restricted Share Unit (“RSU”) Incentive Plan approved by the board of directors of the Company on June 8, 2015, restricted stock units to acquire common shares of the Company may be granted to specified service providers of the Company in accordance with the terms and conditions of the plan. Upon vesting, each RSU entitles the participant to receive one common share, provided that the participant is continuously employed with or providing services to the Company. RSUs track the value of the underlying common shares, but do not entitle the recipient to the underlying common shares until such RSUs vest, nor do they entitle a holder to exercise voting rights or any other rights attached to ownership or control of the common shares, until the RSU vests and the RSU participant receives common shares. A summary of the Company’s RSU’s are as follows: Schedule of restricted share units Number of RSUs Outstanding, December 31, 2019 33,333 Issued 100,000 Vested (133,333 ) Outstanding, December 31, 2020 — Issued 166,000 Outstanding, December 31, 2021 166,000 Vested (166,000 ) Outstanding, December 31, 2022 — On April 27, 2021 the Company issued 166,000 RSU’s to directors and officers of the Company that vested on November 17, 2022. At December 31, 2022, there were nil RSUs outstanding (December 31, 2021: 166,000; December 31, 2020: nil). During the year ended December 31, 2022, the Company recorded $696 (December 31, 2021: $ 216 109 14.6 Deferred Share Units Pursuant to the Company’s Deferred Share Unit (“DSU”) Incentive Plan approved by the board of directors of the Company on July 8, 2018, deferred stock units to acquire common shares of the Company may be granted to specified board members of the Company in accordance with the terms and conditions of the plan. Each DSU entitles the participant to receive one common share upon vesting. DSUs vest into common shares on the board members’ separation date from the board of directors. DSUs track the value of the underlying common shares, but do not entitle the recipient to the underlying common shares until such DSUs vest, nor do they entitle a holder to exercise voting rights or any other rights attached to ownership or control of the common shares, until the DSU vests and the DSU participant receives common shares. A summary of the Company’s DSUs are as follows: Schedule of deferred share units Number of DSUs Outstanding, December 31, 2019 22,619 Issued 72,522 Outstanding, December 31, 2020 95,141 Issued 75,650 Outstanding, December 31, 2021 170,791 Issued 452,910 Outstanding, December 31, 2022 623,701 During the year ended December 31, 2022, the Company issued 452,910 DSUs (December 31, 2021: 75,650 72,522 During the year ended December 31, 2022, the Company recorded $ 569 323 97 |